The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Abstract
Considerable development in the application of injectable drug delivery systems for cancer therapy has occurred in the last few decades. These improvements include liposomes, lipid nanoparticles (LNPs), and other nanoparticles with or without macromolecular conjugates. For example, liposomal doxorubicin modified by poly(ethylene glycol) (Doxil) was the first liposome with anti-cancer effects which was approved by the US Food and Drug Administration, whereas Abraxane (modified albumin nanoparticles loaded by paclitaxel) was recently confirmed for the treatment of breast cancer. Recently, drug delivery systems by LNPs are an emerging technology with numerous advantages over conventional liposomes and chemotherapy using free drug treatment of cancer. These properties are biocompatibility, controlled and sustained release of anti-tumor drugs, and lower toxicity. Valuable experiments on these drug delivery systems offer better treatment of multidrug-resistant cancers and lower cardiotoxicity. LNPs have been presented with high functionality in chemotherapeutic targeting of breast and prostate cancer. The basis for this targeting behavior has been shown to be both passive and active targeting. The main objective of this review was an overview of the current position of the liposome-based drug delivery systems in targeted anticancer chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Peccatori, F. A., Azim, H. A., Orecchia, R., Hoekstra, H. J., Pavlidis, N., Kesic, V., & Pentheroudakis, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt199 · Cited by 790
Therapeutic vaccines for cancer: an overview of clinical trials
Melero, I., Gaudernack, G., Gerritsen, W., Huber, C., Parmiani, G., Scholl, S., Thatcher, N., Wagstaff, J., Zielinski, C., Faulkner, I., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.111 · Cited by 776
Application of liposomes in medicine and drug delivery
Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., & Akbarzadeh, A. (2016) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.3109/21691401.2014.953633 · Cited by 765
Novel methods for liposome preparation
Patil, Y. P., & Jadhav, S. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.10.011 · Cited by 638
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 546
Sánchez-Paulete, A. R., Cueto, F. J., Martínez-López, M., Labiano, S., Morales-Kastresana, A., Rodríguez-Ruiz, M. E., Jure-Kunkel, M., Azpilikueta, A., Aznar, M. A., Quetglas, J. I., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0510 · Cited by 484
Application of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Self-citationPegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Metastasis prevention by targeting the dormant niche
Ghajar, C. M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3910 · Cited by 320
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
Yang, X.-Y., Li, Y.-X., Li, M., Zhang, L., Feng, L.-X., & Zhang, N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.002 · Cited by 262
Mechanisms and kinetics of liposome–cell interactions
Düzgüneş, N., & Nir, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00037-x · Cited by 261
Zhao, X., Li, F., Li, Y., Wang, H., Ren, H., Chen, J., Nie, G., & Hao, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.028 · Cited by 247
Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 240
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release
Luo, D., Carter, K. A., Razi, A., Geng, J., Shao, S., Giraldo, D., Sunar, U., Ortega, J., & Lovell, J. F. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.027 · Cited by 226
Ravar, F., Saadat, E., Gholami, M., Dehghankelishadi, P., Mahdavi, M., Azami, S., & Dorkoosh, F. A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.012 · Cited by 224
Sadegh Malvajerd, S., Azadi, A., Izadi, Z., Kurd, M., Dara, T., Dibaei, M., Sharif Zadeh, M., Akbari Javar, H., & Hamidi, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00510 · Cited by 202
Self-citationWakaskar, R. R. (2018) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1367006 · Cited by 201
Strategies to Increase Drug Penetration in Solid Tumors
Choi, I.-K., Strauss, R., Richter, M., Yun, C.-O., & Lieber, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00193 · Cited by 178
Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy
Barenholz, Y. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017482 · Cited by 177
Nie, F., Yu, X., Huang, M., Wang, Y., Xie, M., Ma, H., Wang, Z., De, W., & Sun, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9611 · Cited by 162
Perez, A. P., Altube, M. J., Schilrreff, P., Apezteguia, G., Celes, F. S., Zacchino, S. A., de Oliveira, C. I., Romero, E. L., & Morilla, M. J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.003 · Cited by 161
Liu, B., Han, L., Liu, J., Han, S., Chen, Z., & Jiang, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s115136 · Cited by 129
Anionic liposomal delivery system for DNA transfection
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2004) · The AAPS Journal · doi:10.1208/aapsj060429 · Cited by 126
Application of cationic liposomes for delivery of nucleic acids
Shim, G., Kim, M., Park, J. Y., & Oh, Y. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.009 · Cited by 123
Modulating effect of lipid bilayer–carotenoid interactions on the property of liposome encapsulation
Xia, S., Tan, C., Zhang, Y., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.02.004 · Cited by 110
Herbal medicines for the treatment of cancer chemotherapy-induced side effects
Ohnishi, S., & Takeda, H. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00014 · Cited by 107
Effects of Drug Hydrophobicity on Liposomal Stability
Khan, D. R., Rezler, E. M., Lauer‐Fields, J. L., & Fields, G. B. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00610.x · Cited by 107
Clemente, N., Ferrara, B., Gigliotti, C. L., Boggio, E. M., Capucchio, M. T., Biasibetti, E., Schiffer, D., Mellai, M., Annovazzi, L., Cangemi, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020255 · Cited by 85
Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice
Guorgui, J. G., Wang, R., Mattheolabakis, G., & Mackenzie, G. G. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.04.012 · Cited by 83
Hamishehkar, H., Bahadori, M. B., Vandghanooni, S., Eskandani, M., Nakhlband, A., & Eskandani, M. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.02.017 · Cited by 75
Liposome Formulations of Hydrophobic Drugs
Schwendener, R. A., & Schott, H. N. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_8 · Cited by 71
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
Kamta, J., Chaar, M., Ande, A., Altomare, D. A., & Ait‐Oudhia, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00064 · Cited by 69
Talluri, S. V., Pindiprolu, S. K. S. S., Chintamaneni, P. K., Tummala, S., & Kumar, S. N. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1313267 · Cited by 64
Jain, M. M., Gupte, S. U., Patil, S. G., Pathak, A. B., Deshmukh, C. D., Bhatt, N., Haritha, C., Babu, G., Bondarde, S. A., Digumarti, R., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3736-9 · Cited by 57
Abdolahpour, S., Toliyat, T., Omidfar, K., Modjtahedi, H., Wong, A. J., Rasaee, M. J., Kashanian, S., & Paknejad, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1296847 · Cited by 49
Tajbakhsh, A., Hasanzadeh, M., Rezaee, M., Khedri, M., Khazaei, M., Shahidsales, S., Ferns, G. A., Hassanian, S. M., & Avan, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25961 · Cited by 48
Xie, J., Codd, C., Mo, K., & He, Y. O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164792 · Cited by 31
Fine-tuning of POPC liposomal leakage by the use of β-cyclodextrin and several hydrophobic guests
Gasbarri, C., Guernelli, S., Boncompagni, S., Angelini, G., Siani, G., Maria, P. D., & Fontana, A. (2009) · Journal of Liposome Research · doi:10.3109/08982100903244526 · Cited by 21
Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma
Takeda, T., Itano, H., Kakehashi, R., Fukita, S., Saitoh, M., & Takeda, S. (2014) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2013.12.003 · Cited by 14
Membrane structure and interactions of peptide hormones with model lipid bilayers
Sikorska, E., Iłowska, E., Wyrzykowski, D., & Kwiatkowska, A. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.07.008 · Cited by 13
Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada.
Perea, J. R. A., & Barberán, J. (2012) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · Cited by 13
Cited by
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J., Melguizo, C., & López-Romero, J. M. (2019) · Nanomaterials · doi:10.3390/nano9040638 · Cited by 527
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Majumder, J., Taratula, O., & Minko, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.010 · Cited by 394
Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy
Zheng, Y., Li, Z., Chen, H., & Gao, Y. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105213 · Cited by 370
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 370
Overcoming barriers by local drug delivery with liposomes
Antimisiaris, S. G., Marazioti, A., Kannavou, M., Natsaridis, E., Gkartziou, F., Kogkos, G., & Mourtas, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.019 · Cited by 339
Metadata
- Authors
- Alavi, M., & Hamidi, M.
- Venue
- Drug Metabolism and Personalized Therapy
- Publisher
- Walter de Gruyter GmbH
- Published
- 2019-02-01
- Volume
- 34
- Issue
- 1
- ISSN
- 2363-8907 (ISSN-L)
- 2363-8915
- OpenAlex
- W2914206423
- Cited by
- 405
- References
- 50
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.